Cargando…

Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features

Objectives: To examine synovial tissue (ST) predictors of clinical differentiation in patients with seronegative undifferentiated peripheral inflammatory arthritis (UPIA). Methods: Fourty-two patients with IgA/IgM-Rheumatoid Factor and anti-citrullinated peptide antibodies negative UPIA, naive to Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Alivernini, Stefano, Tolusso, Barbara, Petricca, Luca, Bui, Laura, Di Mario, Clara, Gigante, Maria R., Di Sante, Gabriele, Benvenuto, Roberta, Fedele, Anna L., Federico, Francesco, Ferraccioli, Gianfranco, Gremese, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037719/
https://www.ncbi.nlm.nih.gov/pubmed/30018954
http://dx.doi.org/10.3389/fmed.2018.00186
_version_ 1783338367724814336
author Alivernini, Stefano
Tolusso, Barbara
Petricca, Luca
Bui, Laura
Di Mario, Clara
Gigante, Maria R.
Di Sante, Gabriele
Benvenuto, Roberta
Fedele, Anna L.
Federico, Francesco
Ferraccioli, Gianfranco
Gremese, Elisa
author_facet Alivernini, Stefano
Tolusso, Barbara
Petricca, Luca
Bui, Laura
Di Mario, Clara
Gigante, Maria R.
Di Sante, Gabriele
Benvenuto, Roberta
Fedele, Anna L.
Federico, Francesco
Ferraccioli, Gianfranco
Gremese, Elisa
author_sort Alivernini, Stefano
collection PubMed
description Objectives: To examine synovial tissue (ST) predictors of clinical differentiation in patients with seronegative undifferentiated peripheral inflammatory arthritis (UPIA). Methods: Fourty-two patients with IgA/IgM-Rheumatoid Factor and anti-citrullinated peptide antibodies negative UPIA, naive to Disease-Modifying Anti-Rheumatic Drugs, underwent Gray Scale (GSUS) and power Doppler (PDUS) evaluation and Ultrasound (US) guided ST biopsy. CD68, CD3, CD21, CD20, and CD31 synovial expression was evaluated by immunohistochemistry. Whole ST microRNA expression was assessed using miScript miRNA PCR Array. Peripheral blood (PB) and synovial fluid (SF) IL-6, VEGF-A, and VEGF-D levels were measured by ELISA and ST TNF expression was assessed by RT-PCR. Each patient was prospectively monitored and classified at baseline and within 1 year as UPIA, Rheumatoid Arthritis (RA), Spondyloarthritis (SpA) or Psoriatic Arthritis (PsA), respectively. Results: At baseline, CD68(+) cells were the most common cells within the lining layer (p < 0.001) in seronegative UPIA, directly correlating with GSUS (R = 0.36; p = 0.02) and PDUS (R = 0.55; p < 0.001). Synovial CD31(+) vessels count directly correlated with GSUS (R = 0.41; p = 0.01) and PDUS (R = 0.52; p < 0.001). During the follow-up, 6 (14.3%) UPIA reached a definite diagnosis (2 RA, 2 SpA and 2 PsA, respectively). At baseline, UPIA who differentiated had higher GSUS (p = 0.01), PDUS scores (p = 0.02) and higher histological scores for CD68(+) (p = 0.005 and p = 0.04 for lining and sublining respectively), sublining CD3(+) cells (p = 0.002), CD31(+) vessels count (p < 0.001) and higher IL-6 PB levels (p = 0.01) than patients who remained as UPIA. MiRNA PCR Array showed that among the 86 tested miRNA species, at baseline, miR-346 and miR-214 were significantly down-regulated (p = 0.02 for both) in ST of UPIA who differentiated than in patients who remained as UPIA, inversely correlating with the lining CD68(+) cells IHC score (R = −0.641; p = 0.048) and CD31(+) vessels count (R = −0.665; p = 0.036) and with higher baseline ST expression of TNF (p = 0.014). Finally, logistic regression analysis demonstrated that baseline GSUS and PDUS scores ≥1.5 [OR:22.93 (95%CI:0.98–534.30)] and CD31(+) vessels count ≥24.3 [OR:23.66 (95%CI:1.50–373.02)] were independent factors associated with the development of definite arthritis. Conclusions: MiRNA signature, histological and US features of ST may help in the identification of seronegative UPIA with high likelihood of clinical differentiation toward definite seronegative arthritis.
format Online
Article
Text
id pubmed-6037719
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60377192018-07-17 Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features Alivernini, Stefano Tolusso, Barbara Petricca, Luca Bui, Laura Di Mario, Clara Gigante, Maria R. Di Sante, Gabriele Benvenuto, Roberta Fedele, Anna L. Federico, Francesco Ferraccioli, Gianfranco Gremese, Elisa Front Med (Lausanne) Medicine Objectives: To examine synovial tissue (ST) predictors of clinical differentiation in patients with seronegative undifferentiated peripheral inflammatory arthritis (UPIA). Methods: Fourty-two patients with IgA/IgM-Rheumatoid Factor and anti-citrullinated peptide antibodies negative UPIA, naive to Disease-Modifying Anti-Rheumatic Drugs, underwent Gray Scale (GSUS) and power Doppler (PDUS) evaluation and Ultrasound (US) guided ST biopsy. CD68, CD3, CD21, CD20, and CD31 synovial expression was evaluated by immunohistochemistry. Whole ST microRNA expression was assessed using miScript miRNA PCR Array. Peripheral blood (PB) and synovial fluid (SF) IL-6, VEGF-A, and VEGF-D levels were measured by ELISA and ST TNF expression was assessed by RT-PCR. Each patient was prospectively monitored and classified at baseline and within 1 year as UPIA, Rheumatoid Arthritis (RA), Spondyloarthritis (SpA) or Psoriatic Arthritis (PsA), respectively. Results: At baseline, CD68(+) cells were the most common cells within the lining layer (p < 0.001) in seronegative UPIA, directly correlating with GSUS (R = 0.36; p = 0.02) and PDUS (R = 0.55; p < 0.001). Synovial CD31(+) vessels count directly correlated with GSUS (R = 0.41; p = 0.01) and PDUS (R = 0.52; p < 0.001). During the follow-up, 6 (14.3%) UPIA reached a definite diagnosis (2 RA, 2 SpA and 2 PsA, respectively). At baseline, UPIA who differentiated had higher GSUS (p = 0.01), PDUS scores (p = 0.02) and higher histological scores for CD68(+) (p = 0.005 and p = 0.04 for lining and sublining respectively), sublining CD3(+) cells (p = 0.002), CD31(+) vessels count (p < 0.001) and higher IL-6 PB levels (p = 0.01) than patients who remained as UPIA. MiRNA PCR Array showed that among the 86 tested miRNA species, at baseline, miR-346 and miR-214 were significantly down-regulated (p = 0.02 for both) in ST of UPIA who differentiated than in patients who remained as UPIA, inversely correlating with the lining CD68(+) cells IHC score (R = −0.641; p = 0.048) and CD31(+) vessels count (R = −0.665; p = 0.036) and with higher baseline ST expression of TNF (p = 0.014). Finally, logistic regression analysis demonstrated that baseline GSUS and PDUS scores ≥1.5 [OR:22.93 (95%CI:0.98–534.30)] and CD31(+) vessels count ≥24.3 [OR:23.66 (95%CI:1.50–373.02)] were independent factors associated with the development of definite arthritis. Conclusions: MiRNA signature, histological and US features of ST may help in the identification of seronegative UPIA with high likelihood of clinical differentiation toward definite seronegative arthritis. Frontiers Media S.A. 2018-07-03 /pmc/articles/PMC6037719/ /pubmed/30018954 http://dx.doi.org/10.3389/fmed.2018.00186 Text en Copyright © 2018 Alivernini, Tolusso, Petricca, Bui, Di Mario, Gigante, Di Sante, Benvenuto, Fedele, Federico, Ferraccioli and Gremese. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Alivernini, Stefano
Tolusso, Barbara
Petricca, Luca
Bui, Laura
Di Mario, Clara
Gigante, Maria R.
Di Sante, Gabriele
Benvenuto, Roberta
Fedele, Anna L.
Federico, Francesco
Ferraccioli, Gianfranco
Gremese, Elisa
Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
title Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
title_full Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
title_fullStr Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
title_full_unstemmed Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
title_short Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
title_sort synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: microrna signature, histological, and ultrasound features
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037719/
https://www.ncbi.nlm.nih.gov/pubmed/30018954
http://dx.doi.org/10.3389/fmed.2018.00186
work_keys_str_mv AT aliverninistefano synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT tolussobarbara synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT petriccaluca synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT builaura synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT dimarioclara synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT gigantemariar synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT disantegabriele synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT benvenutoroberta synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT fedeleannal synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT federicofrancesco synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT ferraccioligianfranco synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures
AT gremeseelisa synovialpredictorsofdifferentiationtodefinitearthritisinpatientswithseronegativeundifferentiatedperipheralinflammatoryarthritismicrornasignaturehistologicalandultrasoundfeatures